Current status of tissue markers as prognostic factors in prostatic adenocarcinoma
β Scribed by Elizabeth H. Hammond; David J. Grignon
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 506 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The expression of proliferating cell nuclear antigen and p53 protein was analysed by immunocy-tochemical methods (PC 10, CM I antisera) in I39 patients with TI -2M0 prostatic adenocarcinomas followed-up for > 12 years. p53 protein was expressed in 2 I ( IS0/o) tumours ( 15%). the fraction of positiv
Platelet-derived growth factor (PDGF) in the resected pulmonary adenocarcinoma tissue of 88 patients was detected immunohistochemically by the avidin-biotin-peroxidase technique to determine whether or not it is a prognostic parameter. The 88 patients were divided into PDGF (-) and PDGF (+) groups a
## Background: The natural history of prostatic cancer is variable. our knowledge of prognostic factors is limited; therefore, research is needed. ## Methods: The cases of 300 population-based consecutive patients with a diagnosis of cancer of the prostate were analyzed regarding different progno
## Abstract ## Introduction The purpose of the present study was to detect the presence of BASCβlike stem cellβrelated indicators, such as clara cell secretory protein (CCSP), Octamerβ4 (OCT4) and Bmiβ1, and evaluate their implications in the prognosis of patients with lung adenocarcinoma. ## Met